Damaged opiate vials at hospital 'likely a manufacturing fault'
- Credit: Denise Bradley
A hospital probe over damaged vials containing an opiate drug 50 times stronger than heroin has found the problem was likely a manufacturing fault.
The James Paget University Hospital in Gorleston had questioned theatre staff after eight incidents of damaged or broken fentanyl vials being found during 2020.
A letter at the time to staff said it was most likely that the fentanyl vials were being tampered with to either cause disruption, gain financially or for personal use.
But now hospital chiefs have now admitted that the likely cause of the damaged vials was a manufacturing fault.
Bosses are writing to all those involved in the investigation to thank them for their support during what they call a "difficult and necessary process".
You may also want to watch:
A statement from the hospital said: “Last year, the trust’s monitoring of controlled drugs and safety procedures picked up an increased incidence of unexplained damage to vials containing fentanyl.
"Any incident involving a controlled drug must be reported and an investigation was opened to look into this increase in more detail.
- 1 Third teenager arrested over Yarmouth park stabbing
- 2 Tesco applies to sell alcohol from pub site
- 3 Seaside cafe opens new toy library for dogs
- 4 Revealed: The most expensive towns to buy a home in Norfolk
- 5 Crowds pour on to streets to enjoy light and sound display
- 6 Thrilling Fire on the Water show to light up Yarmouth
- 7 They started life in lockdown - but how are these businesses doing now?
- 8 Gorleston high street closed this week for emergency gas works
- 9 The most popular baby names in Norfolk in 2020 are revealed
- 10 Award-winning Halloween event returns to Great Yarmouth this half term
"As part of this investigation staff in the area concerned were initially written to and given details about how they could safely come forward with any information they thought might be relevant, should they wish to, and to ensure they knew that support was available.
"Several members of staff were also interviewed during the course of this enquiry, as the trust takes all medication related incidents very seriously, and it was important to determine what had happened.
"The investigation considered a number of options that may be at the root of the increase of the incidents, including the possibility of a manufacturing fault.
"After information was obtained from the manufacturer, it was determined that this was the most likely explanation for the incidents as no evidence of the misuse of controlled drugs was found.
"We recognise that this investigation has had an impact on our staff. A letter is being sent to all of those affected which will thank them for their support during this difficult but necessary process.”